In recent years, an extremely rapid increase has been observed in the incidence of HPV infections. This rapid increase is a result of the very easy transmission of the virus. HPV causes genital warts, which are the most common sexually transmitted disease. A sexually active woman has a 75% chance of being infected with HPV in her lifetime.
Most of the infections within this scope are asymptomatic or show mild symptoms. When they show symptoms, the symptom is usually in the form of a wart in the genital area. The most vicious feature of this virus is that it settles in the cervix and insidiously causes cervical cancer, without showing symptoms in the form of warts.
Even if your smear test results are normal, your probability of being infected with HPV is 25%, if you are under 35 years of age. If there is a problem in your smear test results, your probability of carrying HPV is 50.2%.
When a wart or any similar condition is detected, it is definitely necessary to perform gynecological examination. The existing lesion is analyzed for warts. If the lesions are warts, they should be removed with a procedure deemed appropriate by the doctor. The most important issue that should not be ignored is whether the spouse or sexual partner has warts as well. If the patient’s spouse or sexual partner has genital warts, an appropriate treatment procedure should be performed on him/her without delay. Some types of HPV only cause warts, while some others cause both warts and cancer.
Regarding HPV Vaccines, recommendations of TCSB (Turkish Ministry of Health) Cancer Department, FDA (Food and Drug Administration) and ACIP (Advisory Committee on Immunization Practices) are exactly the same.
HPV vaccines have protective properties, and they are produced with recombinant technology. Two types of HPV vaccines are available in our country. Some of the vaccines contain virus-like particles for protection against HPV Type 16 and HPV Type 18. Other vaccines contain similar particles for protection against HPV Type 6, HPV Type 11, HPV Type 16 and HPV Type 18. Both HPV vaccines are given intramuscularly. Those in the 9 to 14 age group are given two doses at 0-6months, and those 15 years of age and above are given three doses at 0-1 and 6 months. Those in the 9-13 age group are given two doses at 0-6months, and those 14 years of age and above are given three doses at 0-2 and 6 months. The vaccine has been proven to be 100% effective in preventing warts caused by HPV types 6 and 11.